PART I AEON is a biopharmaceutical company advancing its proprietary botulinum toxin complex ABP-450 as a biosimilar to Botox (onabotulinumtoxinA) with the goal of achieving full-label United States (U.S.) market entry for debilitating medical conditions. On December 12, 2022, AEON Biopharma Sub, Inc. (formerly known as AEON Biopharma, Inc.) (Old AEON) and Priveterra Merger Sub, Inc., a wholly owned subsidiary of Priveterra Acquisition Corp. (Priveterra), a special purpose acquisition company fo...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001837607-26-000019 | EDGAR | 96K words |
| 2025-03-24 | 2024-12-31 | 0001837607-25-000022 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001837607-24-000015 | EDGAR | — |
| 2023-02-22 | 2022-12-31 | 0001104659-23-023947 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001104659-22-038759 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044781 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001837607-25-000085 | EDGAR | 31K words |
| 2025-08-12 | 2025-06-30 | 0001837607-25-000066 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001837607-25-000050 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001837607-24-000093 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001558370-24-011896 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001837607-24-000063 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018706 | EDGAR | — |
| 2023-07-21 | 2023-06-30 | 0001104659-23-082959 | EDGAR | — |
| 2023-05-17 | 2023-03-31 | 0001104659-23-061821 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001104659-22-117341 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001104659-22-090142 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001104659-22-059538 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-03 | 0001837607-26-000057 | EDGAR | — |
| 2026-07-23 | 0001837607-26-000055 | EDGAR | — |
| 2026-07-15 | 0001837607-26-000052 | EDGAR | — |
| 2026-04-03 | 0001837607-26-000025 | EDGAR | 1K words |
| 2026-03-30 | 0001837607-26-000018 | EDGAR | — |
| 2026-03-09 | 0001837607-26-000009 | EDGAR | — |
| 2026-01-21 | 0001837607-26-000005 | EDGAR | — |
| 2026-01-12 | 0001837607-26-000002 | EDGAR | — |
| 2025-12-15 | 0001837607-25-000092 | EDGAR | — |
| 2025-12-04 | 0001837607-25-000088 | EDGAR | — |
133 total filings indexed. 105 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001837607 |
| Ticker | AEON |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aeonbiopharma.com |
| Listed | 2023-07-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AEON (~200 tokens, structured JSON with cryptographic provenance)